Rankings
▼
Calendar
TARA Q1 2016 Earnings — Protara Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
TARA
Protara Therapeutics, Inc.
$216M
Q1 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$7M
Net Income
-$7M
EPS (Diluted)
$-15.98
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$6M
Free Cash Flow
-$6M
Stock-Based Comp.
$866,000
Balance Sheet
Total Assets
$61M
Total Liabilities
$4M
Stockholders' Equity
$58M
Cash & Equivalents
$24M
← FY 2016
All Quarters
Q2 2016 →